Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
abbvie
abbvie
Contributing Writer
By
Coins2Day Editors
October 31, 2025
Contributing Writer
By
Coins2Day Editors
July 31, 2025
Politics
Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By
Ryan Hogg
April 30, 2025
Contributing Writer
By
Coins2Day Editors
April 25, 2025
Contributing Writer
By
Coins2Day Editors
January 31, 2025
Health
Hope for Parkinson’s disease symptoms is found in late-stage drug study
By
Beth Greenfield
December 10, 2024
Finance
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
By
Will Daniel
April 23, 2024
Leadership
From financial wellness benefits to reskilling programs: How HR execs at Lockheed Martin, UPS, and 7 other Coins2Day 500 companies are recession-proofing their talent strategy
By
Amber Burton
,
Paige McGlauflin
and
Paolo Confino
March 20, 2023
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By
Paige McGlauflin
August 15, 2022
Health
Will AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?
By
Sy Mukherjee
May 19, 2021
Magazine
Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
By
Geoff Colvin
April 8, 2021
Health
It’s the New Year, and pharma companies are already hiking prices for popular drugs
By
Sy Mukherjee
January 4, 2021
Magazine
What the World’s 25 Best Workplaces have in common
By
Brett Haensel
October 19, 2020
MPW
Three more women have died from cancer linked to Allergan’s recalled breast implants, FDA says
By
Maria Aspan
August 24, 2020
Magazine
‘They killed her’: Why are breast implants still putting millions of women at risk?
By
Maria Aspan
May 18, 2020
Most Popular
Europe
Denmark offered to trade Greenland to the U.S. in 1910—and America thought it was crazy
By
Steven Lamy
and
The Conversation
Personal Finance
Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
By
Miranda Sheild Johansson
and
The Conversation
North America
Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
By
Sydney Lake